ArticleThoracic cancer2023

Survival outcomes of east Asian patients with advanced non-small cell lung cancer treated with first-line EGFR tyrosine kinase inhibitors: A network meta-analysis of real-world evidence.

Huang-Chih Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.